Dynamics of transforming growth factor β signaling and therapeutic efficacy

References

• Abnaof, Khalid, Nikhil Mallela, Gudrun Walenda, Steffen K. Meurer, Kristin Seré, Qiong Lin, Bert Smeets, et al. 2014. “TGF-β Stimulation in Human and Murine Cells Reveals Commonly Affected Biological Processes and Pathways at Transcription Level.” BMC Systems Biology 8 (1): 55. doi:10.1186/1752-0509-8-55.
   PubMedGoogle Scholar
• Amento, Edward P., and L. Steven Beck. 2007. “TGF-β and Wound Healing.” In Ciba Foundation Symposium 157 ‐ Clinical Applications of TGF‐β, 115–136.
   Google Scholar
• Annes, Justin P., Yan Chen, John S. Munger, and Daniel B. Rifkin. 2004. “Integrin αVβ6-Mediated Activation of Latent TGF-β Requires the Latent TGF-β Binding Protein-1.” The Journal of Cell Biology 165 (5): 723–734. doi:10.1083/jcb.200312172.
   PubMed Web of Science ®Google Scholar
• Annes, Justin P., John S. Munger, and Daniel B. Rifkin. 2003. “Making Sense of Latent TGFβ Activation.” Journal of Cell Science 116 (Pt 2): 217–224. doi:10.1242/jcs.00229.
   PubMed Web of Science ®Google Scholar
• Araki, K., T. Shimura, H. Suzuki, S. Tsutsumi, W. Wada, T. Yajima, T. Kobayahi, N. Kubo, and H. Kuwano. 2011. “E/N-Cadherin Switch Mediates Cancer Progression via TGF-β-Induced Epithelial-to-Mesenchymal Transition in Extrahepatic Cholangiocarcinoma.” British Journal of Cancer 105 (12): 1885–1893. doi:10.1038/bjc.2011.452.
   PubMed Web of Science ®Google Scholar
• Arteaga, Carlos L., R. J. Coffey, Jr, Teresa C. Dugger, Carol M. Mccutchen, Harold L. Moses, and Russette M. Lyons. 1990. “Growth Stimulation of Human Breast Cancer Cells with anti-Transforming Growth Factor β Antibodies: Evidence for Negative Autocrine Regulation by Transforming Growth Factor β.” Cell Growth & Differentiation1 (8): 367–374.
   PubMedGoogle Scholar
• Azhar, Mohamad, Moying Yin, Ramireddy Bommireddy, John J. Duffy, Junqi Yang, Sharon A. Pawlowski, Gregory P. Boivin, et al. 2009. “Generation of Mice with a Conditional Allele for Transforming Growth Factor Beta 1 Gene.” Genesis 47 (6): 423–431. doi:10.1002/dvg.20516.
   PubMed Web of Science ®Google Scholar
• Bierie, Brian, and Harold L. Moses. 2006. “TGF-β and Cancer.” Cytokine & Growth Factor Reviews 17 (1-2): 29–40. doi:10.1016/j.cytogfr.2005.09.006.
   PubMed Web of Science ®Google Scholar
• Bogdahn, U., P. Hau, G. Stockhammer, N. K. Venkataramana, A. K. Mahapatra, A. Suri, A. Balasubramaniam, et al. 2011. “Targeted Therapy for High-Grade Glioma with the TGF-β2 Inhibitor Trabedersen: Results of a Randomized and Controlled Phase IIb Study.” Neuro-oncology 13 (1): 132–142. doi:10.1093/neuonc/noq142.
   PubMed Web of Science ®Google Scholar
• Böttinger, E. P., J. J. Letterio, and A. B. Roberts. 1997. “Biology of TGF-β in Knockout and Transgenic Mouse Models.” Kidney International 51 (5): 1355–1360. doi:10.1038/ki.1997.185.
   PubMed Web of Science ®Google Scholar
• Brennan, Eoin P., Melissa J. Morine, David W. Walsh, Sarah A. Roxburgh, Maja T. Lindenmeyer, Derek P. Brazil, Peadar Ó. Gaora, et al. 2012. “Next-Generation Sequencing Identifies TGF-β1-Associated Gene Expression Profiles in Renal Epithelial Cells Reiterated in Human Diabetic Nephropathy.” Biochimica et Biophysica Acta 1822 (4): 589–599. doi:10.1016/j.bbadis.2012.01.008.
   PubMed Web of Science ®Google Scholar
• Brodin, G., P. ten Dijke, K. Funa, C. H. Heldin, and M. Landström. 1999. “Increased Smad Expression and Activation Are Associated with Apoptosis in Normal and Malignant Prostate after Castration1.” Cancer Research 59 (11): 2731–2738.
   PubMed Web of Science ®Google Scholar
• Chang, Hsun-Lang, Nancy Gillett, Irene Figari, Alfredo R. Lopez, Michael A. Palladino, and Rik Derynck. 1993. “Increased Transforming Growth Factor β Expression Inhibits Cell Proliferation in Vitro, yet Increases Tumorigenicity and Tumor Growth of Meth a Sarcoma Cells1.” Cancer Research 53 (18): 4391–4398.
   PubMed Web of Science ®Google Scholar
• Chapnick, Douglas A., Lisa Warner, Jennifer Bernet, Timsi Rao, and Xuedong Liu. 2011. “Partners in Crime: The TGFβ and MAPK Pathways in Cancer Progression.” Cell & Bioscience 1 (1): 42. doi:10.1186/2045-3701-1-42.
   PubMedGoogle Scholar
• Chen, Hao., Thomas M. B. Ware, Josephine Iaria, and Hong-Jian Zhu. 2018. “Live Cell Imaging of the TGF-Beta/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System.” Journal of Visualized Experiments 2018 (137): e57926. doi:10.3791/57926.
   Google Scholar
• Chen, Jian, Sobia Zaidi, Shuyun Rao, Jiun-Sheng Chen, Liem Phan, Patrizia Farci, Xiaoping Su, et al. 2018. “Analysis of Genomes and Transcriptomes of Hepatocellular Carcinomas Identifies Mutations and Gene Expression Changes in the Transforming Growth Factor-β Pathway.” Gastroenterology 154 (1): 195–210. doi:10.1053/j.gastro.2017.09.007.
   PubMed Web of Science ®Google Scholar
• de Gramont, Armand, Sandrine Faivre, and Eric Raymond. 2017. “Novel TGF-β Inhibitors Ready for Prime Time in Onco-Immunology.” Oncoimmunology 6 (1): e1257453. doi:10.1080/2162402x.2016.1257453.
   PubMed Web of Science ®Google Scholar
• de Jong, Marion, and Theodosia Maina. 2010. “Of Mice and Humans: Are They the Same?—Implications in Cancer Translational Research.” Journal of Nuclear Medicine 51 (4): 501–504. doi:10.2967/jnumed.109.065706.
   PubMed Web of Science ®Google Scholar
• de Kruijf, E. M., T. J. A. Dekker, L. J. A. C. Hawinkels, H. Putter, V. T. H. B. M. Smit, J. R. Kroep, P. J. K. Kuppen, et al. 2013. “The Prognostic Role of TGF-Beta Signaling Pathway in Breast Cancer Patients.” Annals of Oncology 24 (2): 384–390. doi:10.1093/annonc/mds333.
   PubMed Web of Science ®Google Scholar
• Deheuninck, Julien, and Kunxin Luo. 2009. “Ski and SnoN, Potent Negative Regulators of TGF-β Signaling.” Cell Research 19 (1): 47–57. doi:10.1038/cr.2008.324.
   PubMed Web of Science ®Google Scholar
• Dennler, S., S. Itoh, D. Vivien, P. ten Dijke, S. Huet, and J. M. Gauthier. 1998. “Direct Binding of Smad3 and Smad4 to Critical TGFβ-Inducible Elements in the Promoter of Human Plasminogen Activator Inhibitor-Type 1 Gene.” The EMBO Journal 17 (11): 3091–3100. doi:10.1093/emboj/17.11.3091.
   PubMed Web of Science ®Google Scholar
• Derynck, Rik, Rosemary J. Akhurst, and Allan Balmain. 2001. “TGF-β Signaling in Tumor Suppression and Cancer Progression.” Nature Genetics 29 (2): 117–129. doi:10.1038/ng1001-117.
   PubMed Web of Science ®Google Scholar
• Donovan, Jeffrey, and Joyce Slingerland. 2000. “Transforming Growth Factor-β and Breast Cancer: Cell Cycle Arrest by Transforming Growth Factor-β and Its Disruption in Cancer.” Breast Cancer Research 2 (2): 116–124. doi:10.1186/bcr43.
   PubMed Web of Science ®Google Scholar
• Emami, Neda, Zahra Sedaei, and Reza Ferdousi. 2021. “Computerized Cell Tracking: Current Methods, Tools and Challenges.” Visual Informatics 5 (1): 1–13. doi:10.1016/j.visinf.2020.11.003.
   Google Scholar
• Fang, Josephine Y., Shih-Jye Tan, Yi-Chen Wu, Zhi Yang, Ba. X. Hoang, and Bo Han. 2016. “From Competency to Dormancy: A 3D Model to Study Cancer Cells and Drug Responsiveness.” Journal of Translational Medicine 14 (1): 38. doi:10.1186/s12967-016-0798-8.
   PubMedGoogle Scholar
• Feng, Xin-Hua, Yao-Yun Liang, Min Liang, Weiguo Zhai, and Xia Lin. 2002. “Direct Interaction of c-Myc with Smad2 and Smad3 to Inhibit TGF-β-Mediated Induction of the CDK Inhibitor p15Ink4B.” Molecular Cell 9 (1): 133–143. doi:10.1016/s1097-2765(01)00430-0.
   PubMed Web of Science ®Google Scholar
• Feng, Xin-Hua, Pinglong Xu, and Xia Lin. 2016. TGF-[Beta] Signaling: Methods and Protocols. New York: Springer.
   Google Scholar
• Fonseca Teixeira, Adilson, Josie Iaria, and Hong-Jian Zhu. 2022. “Fast Quantitation of TGF-β Signaling Using Adenoviral Reporter.” TGF-Beta Signaling. New York, NY: Springer US.
   Google Scholar
• Fu, Lin., Chun-Ping Cui, Xueli Zhang, and Lingqiang Zhang. 2020. “The Functions and Regulation of Smurfs in Cancers.” Seminars in Cancer Biology 67 (Pt 2): 102–116. doi:10.1016/j.semcancer.2019.12.023.
   PubMedGoogle Scholar
• Giampieri, Silvia, Cerys Manning, Steven Hooper, Louise Jones, Caroline S. Hill, and Erik Sahai. 2009. “Localized and Reversible TGFβ Signalling Switches Breast Cancer Cells from Cohesive to Single Cell Motility.” Nature Cell Biology 11 (11): 1287–1296. doi:10.1038/ncb1973.
   PubMed Web of Science ®Google Scholar
• Goldman, Robert D., Jason R. Swedlow, and David L. Spector. 2010. Live Cell Imaging: A Laboratory Manual. Harbor, NY: Cold Spring Harbor Laboratory Press.
   Google Scholar
• Guerrero-Martínez, Jose A., María Ceballos-Chávez, Florian Koehler, Sandra Peiró, and Jose C. Reyes. 2020. “TGFβ Promotes Widespread Enhancer Chromatin Opening and Operates on Genomic Regulatory Domains.” Nature Communications 11 (1): 6196. doi:10.1038/s41467-020-19877-5.
   PubMed Web of Science ®Google Scholar
• Gulhati, Pat., Kanika A. Bowen, Jianyu Liu, Payton D. Stevens, Piotr G. Rychahou, Min Chen, Eun Y. Lee, et al. 2011. “mTORC1 and mTORC2 Regulate EMT, Motility, and Metastasis of Colorectal Cancer via RhoA and Rac1 Signaling Pathways.” Cancer Research 71 (9): 3246–3256. doi:10.1158/0008-5472.can-10-4058.
   PubMed Web of Science ®Google Scholar
• Gunasinghe, N. P. A., Devika, Alan, Wells , Erik W. Thompson, and Honor J. Hugo. 2012. “Mesenchymal–Epithelial Transition (MET) as a Mechanism for Metastatic Colonisation in Breast.” Cancer Metastasis Reviews 31 (3–4): 469–478. doi:10.1007/s10555-012-9377-5.
   PubMed Web of Science ®Google Scholar
• Halder, Sunil K., R. Daniel Beauchamp, and Pran K. Datta. 2005. “A Specific Inhibitor of TGF-β Receptor Kinase, SB-431542, as a Potent Antitumor Agent for Human Cancers.” Neoplasia 7 (5): 509–521. doi:10.1593/neo.04640.
   PubMed Web of Science ®Google Scholar
• Hamidi, Anahita, Jie Song, Noopur Thakur, Susumu Itoh, Anders Marcusson, Anders Bergh, Carl-Henrik Heldin, and Maréne Landström. 2017. “TGF-β Promotes PI3K-AKT Signaling and Prostate Cancer Cell Migration through the TRAF6-Mediated Ubiquitylation of p85α.” Science Signaling 10 (486): eaal4186. doi:10.1126/scisignal.aal4186.
   PubMed Web of Science ®Google Scholar
• Haque, Sulsal, and John C. Morris. 2017. “Transforming Growth Factor-β: A Therapeutic Target for Cancer.” Human Vaccines & Immunotherapeutics 13 (8): 1741–1750. doi:10.1080/21645515.2017.1327107.
   PubMed Web of Science ®Google Scholar
• Hasegawa, Yukihiro, Shingo Takanashi, Yutaka Kanehira, Takao Tsushima, Tadashi Imai, and Ken Okumura. 2001. “Transforming Growth Factor‐β1 Level Correlates with Angiogenesis, Tumor Progression, and Prognosis in Patients with Non-Small Cell Lung Carcinoma.” Cancer 91 (5): 964–971. doi:10.1002/1097-0142(20010301)91:5<964::AID-CNCR1086>3.0.CO;2-O.
   PubMed Web of Science ®Google Scholar
• Hawinkels, L. J. A. C., H. W. Verspaget, W. van Duijn, J. M. van der Zon, K. Zuidwijk, F. J. G. M. Kubben, J. H. Verheijen, D. W. Hommes, C. B. H. W. Lamers, and C. F. M. Sier. 2007. “Tissue Level, Activation and Cellular Localisation of TGF-β1 and Association with Survival in Gastric Cancer Patients.” British Journal of Cancer 97 (3): 398–404. doi:10.1038/sj.bjc.6603877.
   PubMed Web of Science ®Google Scholar
• Hayashi, H., S. Abdollah, Y. Qiu, J. Cai, Y. Y. Xu, B. W. Grinnell, M. A. Richardson, et al. 1997. “The MAD-Related Protein Smad7 Associates with the TGFβ Receptor and Functions as an Antagonist of TGFβ Signaling.” Cell 89 (7): 1165–1173. doi:10.1016/S0092-8674(00)80303-7.
   PubMed Web of Science ®Google Scholar
• Hoosein, N. M., M. K. McKnight, A. E. Levine, K. M. Mulder, K. E. Childress, D. E. Brattain, and M. G. Brattain. 1989. “Differential Sensitivity of Subclasses of Human Colon Carcinoma Cell Lines to the Growth Inhibitory Effects of Transforming Growth Factor-β1.” Experimental Cell Research 181 (2): 442–453. doi:10.1016/0014-4827(89)90101-8.
   PubMed Web of Science ®Google Scholar
• Horiguchi, Masahito, Mitsuhiko Ota, and Daniel B. Rifkin. 2012. “Matrix Control of Transforming Growth Factor-β Function.” Journal of Biochemistry 152 (4): 321–329. doi:10.1093/jb/mvs089.
   PubMed Web of Science ®Google Scholar
• Hu, Huizhong, Alexey Goltsov, James L. Bown, Andrew H. Sims, Simon P. Langdon, David J. Harrison, and Dana Faratian. 2013. “Feedforward and Feedback Regulation of the MAPK and PI3K Oscillatory Circuit in Breast Cancer.” Cellular Signalling 25 (1): 26–32. doi:10.1016/j.cellsig.2012.09.014.
   PubMed Web of Science ®Google Scholar
• Huang, Cheng-Yi, Chih-Ling Chung, Tsung-Hui Hu, Jih-Jung Chen, Pei-Feng Liu, and Chun-Lin Chen. 2021. “Recent Progress in TGF-β Inhibitors for Cancer Therapy.” Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 134: 111046. doi:10.1016/j.biopha.2020.111046.
   PubMed Web of Science ®Google Scholar
• Huang, Fei, and Ye-Guang Chen. 2012. “Regulation of TGF-β Receptor Activity.” Cell & Bioscience 2 (1): 9. doi:10.1186/2045-3701-2-9.
   PubMedGoogle Scholar
• Huber-Ruano, I., C. Raventós, I. Cuartas, C. Sánchez-Jaro, A. Arias, J. L. Parra, K. Wosikowski, M. Janicot, and J. Seoane. 2017. “An Antisense Oligonucleotide Targeting TGF-β2 Inhibits Lung Metastasis and Induces CD86 Expression in Tumor-Associated Macrophages.” Annals of Oncology 28 (9): 2278–2285. doi:10.1093/annonc/mdx314.
   PubMed Web of Science ®Google Scholar
• Inoue, Yasumichi, and Takeshi Imamura. 2008. “Regulation of TGF-β Family Signaling by E3 Ubiquitin Ligases.” Cancer Science 99 (11): 2107–2112. doi:10.1111/j.1349-7006.2008.00925.x.
   PubMed Web of Science ®Google Scholar
• Iqbal, Nida, and Naveed Iqbal. 2014. “Imatinib: A Breakthrough of Targeted Therapy in Cancer.” Chemotherapy Research and Practice 2014: 357027. doi:10.1155/2014/357027.
   PubMedGoogle Scholar
• Itoh, Yuka, Daizo Koinuma, Chiho Omata, Tomohiro Ogami, Mitsuyoshi Motizuki, So-Ichi Yaguchi, Takuma Itoh, et al. 2019. “A Comparative Analysis of Smad-Responsive Motifs Identifies Multiple Regulatory Inputs for TGF-β Transcriptional Activation.” The Journal of Biological Chemistry 294 (42): 15466–15479. doi:10.1074/jbc.RA119.009877.
   PubMed Web of Science ®Google Scholar
• Ivanović, Vesna, Miroslav Demajo, Koviljka Krtolica, Milena Krajnović, Miroslav Konstantinović, Vladimir Baltić, Gordana Prtenjak, et al. 2006. “Elevated Plasma TGF-β1 Levels Correlate with Decreased Survival of Metastatic Breast Cancer Patients.” Clinica Chimica Acta; International Journal of Clinical Chemistry 371 (1–2): 191–193. doi:10.1016/j.cca.2006.02.027.
   PubMed Web of Science ®Google Scholar
• Javle, Milind, Yanan Li, Dongfeng Tan, Xiaoqun Dong, Ping Chang, Siddhartha Kar, and Donghui Li. 2014. “Biomarkers of TGF-β Signaling Pathway and Prognosis of Pancreatic Cancer.” PLoS One 9 (1): e85942. doi:10.1371/journal.pone.0085942.
   PubMed Web of Science ®Google Scholar
• Jurukovski, V., B. Dabovic, V. Todorovic, Y. Chen, and D. B. Rifkin. 2005. “Methods for Measuring TGF-b Using Antibodies, Cells, and Mice.” Methods in Molecular Medicine 117: 161–175. doi:10.1385/1-59259-940-0:161.
   PubMedGoogle Scholar
• Kalluri, Raghu, and Eric G. Neilson. 2003. “Epithelial-Mesenchymal Transition and Its Implications for Fibrosis.” The Journal of Clinical Investigation 112 (12): 1776–1784. doi:10.1172/jci20530.
   PubMed Web of Science ®Google Scholar
• Khatibi, Shabnam, Hong-Jian Zhu, John Wagner, Chin Wee Tan, Jonathan H. Manton, and Antony W. Burgess. 2017. “Mathematical Model of TGF-β Signalling: Feedback Coupling is Consistent with Signal Switching.” BMC Systems Biology 11 (1): 48. doi:10.1186/s12918-017-0421-5.
   PubMedGoogle Scholar
• Kholodenko, Boris N. 2006. “Cell-Signalling Dynamics in Time and Space.” Nature Reviews. Molecular Cell Biology 7 (3): 165–176. doi:10.1038/nrm1838.
   PubMed Web of Science ®Google Scholar
• Kim, Se-Hee, Sangtae Choi, and Won-Suk Lee. 2022. “Bevacizumab and Anexelekto Inhibitor, TP-0903 Inhibits TGF-β1-Induced Epithelial–Mesenchymal Transition of Colon Cancer Cells.” Anti-Cancer Drugs 33 (1): e453–e461. doi:10.1097/CAD.0000000000001239.
   PubMed Web of Science ®Google Scholar
• Kobayashi, Tetsu, HuiJung Kim, Xiangde Liu, Hisatoshi Sugiura, Tadashi Kohyama, Qiuhong Fang, Fu-Qiang Wen, et al. 2014. “Matrix Metalloproteinase-9 Activates TGF-β and Stimulates Fibroblast Contraction of Collagen Gels.” American Journal of Physiology 306 (11): L1006–L1015. doi:10.1152/ajplung.00015.2014.
   Google Scholar
• Korol, Anna, Aftab Taiyab, and Judith A. West-Mays. 2016. “RhoA/ROCK Signaling Regulates TGFβ-Induced Epithelial-Mesenchymal Transition of Lens Epithelial Cells through MRTF-A.” Molecular Medicine 22 (1): 713–723. doi:10.2119/molmed.2016.00041.
   PubMed Web of Science ®Google Scholar
• Kubiczkova, Lenka, Lenka Sedlarikova, Roman Hajek, and Sabina Sevcikova. 2012. “TGF-β – An Excellent Servant but a Bad Master.” Journal of Translational Medicine 10 (1): 183. doi:10.1186/1479-5876-10-183.
   PubMedGoogle Scholar
• Kulkarni, Ashok B., and Stefan Karlsson. 1993. “Transforming Growth Factor-Beta 1 Knockout Mice. A Mutation in One Cytokine Gene Causes a Dramatic Inflammatory Disease.” The American Journal of Pathology 143 (1): 3.
   PubMed Web of Science ®Google Scholar
• Lamouille, Samy, and Rik Derynck. 2007. “Cell Size and Invasion in TGF-β–Induced Epithelial to Mesenchymal Transition is Regulated by Activation of the mTOR Pathway.” The Journal of Cell Biology 178 (3): 437–451. doi:10.1083/jcb.200611146.
   PubMed Web of Science ®Google Scholar
• Li, Wenqian, Xiaoxue Zhang, Ji Wang, Mengchen Li, Canhui Cao, Jiahong Tan, Ding Ma, and Qinglei Gao. 2017. “TGFbeta in Fibroblasts-Derived Exosomes Promotes Epithelial-Mesenchymal Transition of Ovarian Cancer Cells.” Oncotarget 8 (56): 96035–96047. doi:10.18632/oncotarget.21635.
   PubMedGoogle Scholar
• Lind, Hanne, Sofia R. Gameiro, Caroline Jochems, Renee N. Donahue, Julius Strauss, James L. Gulley, Claudia Palena, and Jeffrey Schlom. 2020. “Dual Targeting of TGF-β and PD-L1 via a Bifunctional anti-PD-L1/TGF-βRII Agent: Status of Preclinical and Clinical Advances.” Journal for ImmunoTherapy of Cancer 8 (1): e000433. doi:10.1136/jitc-2019-000433.
   PubMed Web of Science ®Google Scholar
• Liu, Jieqiong, Shan Liao, Benjamin Diop-Frimpong, Wei Chen, Shom Goel, Kamila Naxerova, Marek Ancukiewicz, Yves Boucher, Rakesh K. Jain, and Lei Xu. 2012. “TGF-β Blockade Improves the Distribution and Efficacy of Therapeutics in Breast Carcinoma by Normalizing the Tumor Stroma.” Proceedings of the National Academy of Sciences of the United States of America 109 (41): 16618–16623. doi:10.1073/pnas.1117610109.
   PubMed Web of Science ®Google Scholar
• Liu, Sheng, Thao Nheu, Rodney Luwor, Sandra E. Nicholson, and Hong-Jian Zhu. 2015. “SPSB1, a Novel Negative Regulator of the Transforming Growth Factor-β Signaling Pathway Targeting the Type II Receptor.” The Journal of Biological Chemistry 290 (29): 17894–17908. doi:10.1074/jbc.M114.607184.
   PubMed Web of Science ®Google Scholar
• Luwor, R. B., B. Baradaran, L. E. Taylor, J. Iaria, T. V. Nheu, N. Amiry, C. M. Hovens, B. Wang, A. H. Kaye, and H. J. Zhu. 2013. “Targeting Stat3 and Smad7 to Restore TGF-β Cytostatic Regulation of Tumor Cells In Vitro and In Vivo.” Oncogene 32 (19): 2433–2441. doi:10.1038/onc.2012.260.
   PubMed Web of Science ®Google Scholar
• Luwor, Rodney B., Dulani Hakmana, Josephine Iaria, Thao V. Nheu, Richard J. Simpson, and Hong-Jian Zhu. 2015. “Single Live Cell TGF-β Signalling Imaging: Breast Cancer Cell Motility and Migration is Driven by Sub-Populations of Cells with Dynamic TGF-β-Smad3 Activity.” Molecular Cancer 14 (1): 50. doi:10.1186/s12943-015-0309-1.
   PubMedGoogle Scholar
• Luwor, Rodney B., Bo Wang, Thao V. Nheu, Josephine Iaria, Evelyn Tsantikos, Margaret L. Hibbs, Oliver M. Sieber, and Hong-Jian Zhu. 2011. “New Reagents for Improved in Vitro and in Vivo Examination of TGF-β Signalling.” Growth Factors 29 (5): 211–218. doi:10.3109/08977194.2011.615311.
   PubMed Web of Science ®Google Scholar
• Lv, Zhi-Dong, Bin Kong, Jian-Guo Li, Hui-Li Qu, Xin-Gang Wang, Wei-Hong Cao, Xiao-Yi Liu, et al. 2013. “Transforming Growth Factor-β 1 Enhances the Invasiveness of Breast Cancer Cells by Inducing a Smad2-Dependent Epithelial-to-Mesenchymal Transition.” Oncology Reports 29 (1): 219–225. doi:10.3892/or.2012.2111.
   PubMed Web of Science ®Google Scholar
• Macias, Maria J., Pau Martin-Malpartida, and Joan Massagué. 2015. “Structural Determinants of Smad Function in TGF-β Signaling.” Trends in Biochemical Sciences 40 (6): 296–308. doi:10.1016/j.tibs.2015.03.012.
   PubMed Web of Science ®Google Scholar
• Marzo, A. L., D. R. Fitzpatrick, B. W. Robinson, and B. Scott. 1997. “Antisense Oligonucleotides Specific for Transforming Growth Factor β2 Inhibit the Growth of Malignant Mesothelioma Both In Vitro and In Vivo.” Cancer Research 57 (15): 3200–3207.
   PubMed Web of Science ®Google Scholar
• Massagué, J. 1998. “TGF-β Signal Transduction.” Annual Review of Biochemistry 67 (1): 753–791. doi:10.1146/annurev.biochem.67.1.753.
   PubMedGoogle Scholar
• Matsumura, Noriomi, Zhiqing Huang, Seiichi Mori, Tsukasa Baba, Shingo Fujii, Ikuo Konishi, Edwin S. Iversen, Andrew Berchuck, and Susan K. Murphy. 2011. “Epigenetic Suppression of the TGF-Beta Pathway Revealed by Transcriptome Profiling in Ovarian Cancer.” Genome Research 21 (1): 74–82. doi:10.1101/gr.108803.110.
   PubMed Web of Science ®Google Scholar
• Melisi, Davide, Satoshi Ishiyama, Guido M. Sclabas, Jason B. Fleming, Qianghua Xia, Giampaolo Tortora, James L. Abbruzzese, and Paul J. Chiao. 2008. “LY2109761, a Novel Transforming Growth Factor β Receptor Type I and Type II Dual Inhibitor, as a Therapeutic Approach to Suppressing Pancreatic Cancer Metastasis.” Molecular Cancer Therapeutics 7 (4): 829–840. doi:10.1158/1535-7163.mct-07-0337.
   PubMed Web of Science ®Google Scholar
• Meyer-Ter-Vehn, Tobias, Susanne Gebhardt, Walter Sebald, Mathias Buttmann, Franz Grehn, Günther Schlunck, and Petra Knaus. 2006. “p38 Inhibitors Prevent TGF-β–Induced Myofibroblast Transdifferentiation in Human Tenon Fibroblasts.” Investigative Ophthalmology & Visual Science 47 (4): 1500–1509. doi:10.1167/iovs.05-0361.
   PubMed Web of Science ®Google Scholar
• Miyazono, K. 2000. “Positive and Negative Regulation of TGF-Beta Signaling.” Journal of Cell Science 113 (7): 1101–1109. doi:10.1242/jcs.113.7.1101.
   PubMed Web of Science ®Google Scholar
• Moustakas, A., and C. H. Heldin. 2016. “Mechanisms of TGFβ-Induced Epithelial-Mesenchymal Transition.” Journal of Clinical Medicine 5 (7): 63. doi:10.3390/jcm5070063.
   PubMed Web of Science ®Google Scholar
• Mulder, Kathleen M. 2000. “Role of Ras and Mapks in TGFβ Signaling.” Cytokine & Growth Factor Reviews 11 (1–2): 23–35. doi:10.1016/S1359-6101(99)00026-X.
   PubMed Web of Science ®Google Scholar
• Munger, J. S., X. Huang, H. Kawakatsu, M. J. Griffiths, S. L. Dalton, J. Wu, J. F. Pittet, et al. 1999. “A Mechanism for Regulating Pulmonary Inflammation and Fibrosis: The Integrin αvβ6 Binds and Activates Latent TGF β1.” Cell 96 (3): 319–328. doi:10.1016/S0092-8674(00)80545-0.
   PubMed Web of Science ®Google Scholar
• Muraoka-Cook, Rebecca S., Hirokazu Kurokawa, Yasuhiro Koh, James T. Forbes, L. Renee Roebuck, Mary Helen Barcellos-Hoff, Susan E. Moody, Lewis A. Chodosh, and Carlos L. Arteaga. 2004. “Conditional Overexpression of Active Transforming Growth Factor β1 In Vivo Accelerates Metastases of Transgenic Mammary Tumors.” Cancer Research 64 (24): 9002–9011. doi:10.1158/0008-5472.can-04-2111.
   PubMed Web of Science ®Google Scholar
• Nagaraj, Nagathihalli S., and Pran K. Datta. 2010. “Targeting the Transforming Growth Factor-β Signaling Pathway in Human Cancer.” Expert Opinion on Investigational Drugs 19 (1): 77–91. doi:10.1517/13543780903382609.
   PubMed Web of Science ®Google Scholar
• Nakao, A., T. Imamura, S. Souchelnytskyi, M. Kawabata, A. Ishisaki, E. Oeda, K. Tamaki, et al. 1997. “TGF-β Receptor-Mediated Signalling through Smad2, Smad3 and Smad4.” The EMBO Journal 16 (17): 5353–5362. doi:10.1093/emboj/16.17.5353.
   PubMed Web of Science ®Google Scholar
• Oft, Martin, Janos Peli, Claude Rudaz, Heinz Schwarz, Hartmut Beug, and Ernst Reichmann. 1996. “TGF-Beta1 and Ha-Ras Collaborate in Modulating the Phenotypic Plasticity and Invasiveness of Epithelial Tumor Cells.” Genes & Development 10 (19): 2462–2477. doi:10.1101/gad.10.19.2462.
   PubMed Web of Science ®Google Scholar
• Ozdamar, Barish, Rohit Bose, Miriam Barrios-Rodiles, Hong-Rui Wang, Yue Zhang, and Jeffrey L. Wrana. 2005. “Regulation of the Polarity Protein Par6 by TGFß Receptors Controls Epithelial Cell Plasticity.” Science 307 (5715): 1603–1609. doi:10.1126/science.1105718.
   PubMed Web of Science ®Google Scholar
• Padua, David, and Joan Massagué. 2009. “Roles of TGFβ in Metastasis.” Cell Research 19 (1): 89–102. doi:10.1038/cr.2008.316.
   PubMed Web of Science ®Google Scholar
• Pape, Judith, Mark Emberton, and Umber Cheema. 2021. “3D Cancer Models: The Need for a Complex Stroma, Compartmentalization and Stiffness.” Frontiers in Bioengineering and Biotechnology 9, . 60502 doi: 10.3389/fbioe.2021.660502.
   Web of Science ®Google Scholar
• Pardali, Katerina, and Aristidis Moustakas. 2007. “Actions of TGF-β as Tumor Suppressor and Pro-Metastatic Factor in Human Cancer.” Biochimica et Biophysica Acta 1775 (1): 21–62. doi:10.1016/j.bbcan.2006.06.004.
   PubMed Web of Science ®Google Scholar
• Pickup, Michael, Sergey Novitskiy, and Harold L. Moses. 2013. “The Roles of TGFβ in the Tumour Microenvironment.” Nature Reviews 13 (11): 788–799. doi:10.1038/nrc3603.
   Web of Science ®Google Scholar
• Ranganathan, Prathibha, Animesh Agrawal, Raghu Bhushan, Aravinda K. Chavalmane, Ravi Kiran Reddy Kalathur, Takashi Takahashi, and Paturu Kondaiah. 2007. “Expression Profiling of Genes Regulated by TGF-Beta: Differential Regulation in Normal and Tumour Cells.” BMC Genomics.8 (1): 98. doi:10.1186/1471-2164-8-98.
   PubMedGoogle Scholar
• Ribatti, Domenico, Roberto Tamma, and Tiziana Annese. 2020. “Epithelial-Mesenchymal Transition in Cancer: A Historical Overview.” Translational Oncology 13 (6): 100773. doi:10.1016/j.tranon.2020.100773.
   PubMed Web of Science ®Google Scholar
• Roberts, Anita B., and Lalage M. Wakefield. 2003. “The Two Faces of Transforming Growth Factor β in Carcinogenesis.” Proceedings of the National Academy of Sciences of the United States of America 100 (15): 8621–8623. doi:10.1073/pnas.1633291100.
   PubMed Web of Science ®Google Scholar
• Robson, H., E. Anderson, R. D. James, and P. F. Schofield. 1996. “Transforming Growth Factor β 1 Expression in Human Colorectal Tumours: An Independent Prognostic Marker in a Subgroup of Poor Prognosis Patients.” British Journal of Cancer 74 (5): 753–758. doi:10.1038/bjc.1996.432.
   PubMed Web of Science ®Google Scholar
• Sanford, L. P., I. Ormsby, A. C. Gittenberger-de Groot, H. Sariola, R. Friedman, G. P. Boivin, E. L. Cardell, and T. Doetschman. 1997. “TGFbeta2 Knockout Mice Have Multiple Developmental Defects That Are Non-Overlapping with Other TGFbeta Knockout Phenotypes.” Development 124 (13): 2659–2670. doi:10.1242/dev.124.13.2659.
   PubMedGoogle Scholar
• Sarrazy, Vincent, Anne Koehler, Melissa L. Chow, Elena Zimina, Chen X. Li, Hideyuki Kato, Christopher A. Caldarone, and Boris Hinz. 2014. “Integrins αvβ5 and αvβ3 Promote Latent TGF-β1 Activation by Human Cardiac Fibroblast Contraction.” Cardiovascular Research 102 (3): 407–417. doi:10.1093/cvr/cvu053.
   PubMed Web of Science ®Google Scholar
• Schlingensiepen, Karl-Hermann, Frank Jaschinski, Sven Arke Lang, Christian Moser, Edward Kenneth Geissler, Hans Jürgen Schlitt, Marcus Kielmanowicz, and Anneliese Schneider. 2011. “Transforming Growth Factor-Beta 2 Gene Silencing with Trabedersen (AP 12009) in Pancreatic Cancer.” Cancer Science 102 (6): 1193–1200. doi:10.1111/j.1349-7006.2011.01917.x.
   PubMed Web of Science ®Google Scholar
• Schuster, Norbert, and Kerstin Krieglstein. 2002. “Mechanisms of TGF-β-Mediated Apoptosis.” Cell and Tissue Research 307 (1): 1–14. doi:10.1007/s00441-001-0479-6.
   PubMed Web of Science ®Google Scholar
• Serra, R., and M. R. Crowley. 2005. “Mouse Models of Transforming Growth Factor β Impact in Breast Development and Cancer.” Endocrine-Related Cancer 12 (4): 749–760. doi:10.1677/erc.1.00936.
   PubMed Web of Science ®Google Scholar
• Shelke, Ganesh Vilas, Yanan Yin, Su Chul Jang, Cecilia Lässer, Stefan Wennmalm, Hans Jürgen Hoffmann, Li Li, Yong Song Gho, Jonas Andreas Nilsson, and Jan Lötvall. 2019. “Endosomal Signalling via Exosome Surface TGFβ-1.” Journal of Extracellular Vesicles 8 (1): 1650458. doi:10.1080/20013078.2019.1650458.
   PubMed Web of Science ®Google Scholar
• Shi, Minlong, Jianghai Zhu, Rui Wang, Xing Chen, Lizhi Mi, Thomas Walz, and Timothy A. Springer. 2011. “Latent TGF-β Structure and Activation.” Nature 474 (7351): 343–349. doi:10.1038/nature10152.
   PubMed Web of Science ®Google Scholar
• Shi, Yigong, and Joan Massagué. 2003. “Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus.” Cell 113 (6): 685–700. doi:10.1016/S0092-8674(03)00432-X.
   PubMed Web of Science ®Google Scholar
• Shima, Y., K. Nakao, T. Nakashima, A. Kawakami, K. Nakata, K. Hamasaki, Y. Kato, K. Eguchi, and N. Ishii. 1999. “Activation of Caspase-8 in Transforming Growth Factor-β–Induced Apoptosis of Human Hepatoma Cells.” Hepatology 30 (5): 1215–1222. doi:10.1002/hep.510300503.
   PubMed Web of Science ®Google Scholar
• Song, Jianguo. 2007. “EMT or Apoptosis: A Decision for TGF-β.” Cell Research 17 (4): 289–290. doi:10.1038/cr.2007.25.
   PubMed Web of Science ®Google Scholar
• Stolfi, Carmine, Irene Marafini, Veronica De Simone, Francesco Pallone, and Giovanni Monteleone. 2013. “The Dual Role of Smad7 in the Control of Cancer Growth and Metastasis.” International Journal of Molecular Sciences 14 (12): 23774–23790. doi:10.3390/ijms141223774.
   PubMed Web of Science ®Google Scholar
• Strauss, Julius, Margaret E. Gatti-Mays, Byoung Chul Cho, Andrew Hill, Sébastien Salas, Edward McClay, Jason M. Redman, et al. 2020. “Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Patients with Human Papillomavirus-Associated Malignancies.” Journal for ImmunoTherapy of Cancer 8 (2): e001395. doi:10.1136/jitc-2020-001395.
   PubMed Web of Science ®Google Scholar
• Stroschein, Shannon L., Wei Wang, Sharleen Zhou, Qiang Zhou, and Kunxin Luo. 1999. “Negative Feedback Regulation of TGF-β Signaling by the SnoN Oncoprotein.” Science 286 (5440): 771–774. doi:10.1126/science.286.5440.771.
   PubMed Web of Science ®Google Scholar
• Swedlow, Jason R. 2010. “Advanced Hardware and Software Tools for Fast Multidimensional Imaging of Living Cells.” Proceedings of the National Academy of Sciences of the United States of America 107 (37): 16005–16006. doi:10.1073/pnas.1010043107.
   PubMed Web of Science ®Google Scholar
• Tabe, Yoko, Yue Xi Shi, Zhihong Zeng, Linhua Jin, Masato Shikami, Yasuhito Hatanaka, Takashi Miida, Frank J. Hsu, Michael Andreeff, and Marina Konopleva. 2013. “TGF-β-Neutralizing Antibody 1D11 Enhances Cytarabine-Induced Apoptosis in AML Cells in the Bone Marrow Microenvironment.” PLoS One 8 (6): e62785. doi:10.1371/journal.pone.0062785.
   PubMed Web of Science ®Google Scholar
• Taipale, J., K. Miyazono, C. H. Heldin, and J. Keski-Oja. 1994. “Latent Transforming Growth Factor-Beta 1 Associates to Fibroblast Extracellular Matrix via Latent TGF-Beta Binding Protein.” The Journal of Cell Biology 124 (1–2): 171–181. doi:10.1083/jcb.124.1.171.
   PubMed Web of Science ®Google Scholar
• Tang, Binwu, Mary Vu, Timberly Booker, Steven J. Santner, Fred R. Miller, Miriam R. Anver, and Lalage M. Wakefield. 2003. “TGF-β Switches from Tumor Suppressor to Prometastatic Factor in a Model of Breast Cancer Progression.” The Journal of Clinical Investigation 112 (7): 1116–1124. doi:10.1172/jci18899.
   PubMed Web of Science ®Google Scholar
• Tatler, Amanda L., Alison E. John, Lisa Jolly, Anthony Habgood, Jo Porte, Chris Brightling, Alan J. Knox, et al. 2011. “Integrin αvβ5-Mediated TGF-β Activation by Airway Smooth Muscle Cells in Asthma.” Journal of Immunology 187 (11): 6094–6107. doi:10.4049/jimmunol.1003507.
   PubMed Web of Science ®Google Scholar
• Tecalco-Cruz, Angeles C., Diana G. Ríos-López, Genaro Vázquez-Victorio, Reyna E. Rosales-Alvarez, and Marina Macías-Silva. 2018. “Transcriptional Cofactors Ski and SnoN Are Major Regulators of the TGF-β/Smad Signaling Pathway in Health and Disease.” Signal Transduction and Targeted Therapy 3 (1): 15. doi:10.1038/s41392-018-0015-8.
   PubMedGoogle Scholar
• Teixeira, Adilson Fonseca, Peter ten Dijke, and Hong-Jian Zhu. 2020. “On-Target anti-TGF-β Therapies Are Not Succeeding in Clinical Cancer Treatments: What Are Remaining Challenges?” Frontiers in Cell and Developmental Biology 8, 00605 doi: 10.3389/fcell.2020.00605.
   PubMed Web of Science ®Google Scholar
• Tesseur, Ina., Kun Zou, Elisabeth Berber, Hui Zhang, and Tony Wyss-Coray. 2006. “Highly Sensitive and Specific Bioassay for Measuring Bioactive TGF-β.” BMC Cell Biology 7 (1): 15. doi:10.1186/1471-2121-7-15.
   PubMedGoogle Scholar
• Tosi, Sébastien, and Kyra Campbell. 2019. “3D Tracking of Migrating Cells from Live Microscopy Time-Lapses.” In Computer Optimized Microscopy: Methods and Protocols, edited by Elena Rebollo and Manel Bosch, 385–395. New York, NY: Springer New York.
   Google Scholar
• Valls, Pablo Oriol, and Alessandro Esposito. 2022. “Signalling Dynamics, Cell Decisions, and Homeostatic Control in Health and Disease.” Current Opinion in Cell Biology 75: 102066. doi:10.1016/j.ceb.2022.01.011.
   PubMed Web of Science ®Google Scholar
• Wang, Hao., Meiling Chen, Xiaohong Sang, Xuefu You, Yucheng Wang, Ian C. Paterson, Wei Hong, and Xinyi Yang. 2020. “Development of Small Molecule Inhibitors Targeting TGF-β Ligand and Receptor: Structures, Mechanism, Preclinical Studies and Clinical Usage.” European Journal of Medicinal Chemistry 191: 112154. doi:10.1016/j.ejmech.2020.112154.
   PubMed Web of Science ®Google Scholar
• Warmflash, Aryeh, Qixiang Zhang, Benoit Sorre, Alin Vonica, Eric D. Siggia, and Ali H. Brivanlou. 2012. “Dynamics of TGF-β Signaling Reveal Adaptive and Pulsatile Behaviors Reflected in the Nuclear Localization of Transcription Factor Smad4.” Proceedings of the National Academy of Sciences of the United States of America 109 (28): E1947–E1956. doi:10.1073/pnas.1207607109.
   PubMed Web of Science ®Google Scholar
• Warner, B. J., S. W. Blain, J. Seoane, and J. Massagué. 1999. “Myc Downregulation by Transforming Growth Factor β Required for Activation of the p15Ink4b G1 Arrest Pathway.” Molecular and Cellular Biology 19 (9): 5913–5922. doi:10.1128/mcb.19.9.5913.
   PubMed Web of Science ®Google Scholar
• Wendt, Michael K., Molly A. Taylor, Barbara J. Schiemann, and William P. Schiemann. 2011. “Down-Regulation of Epithelial Cadherin is Required to Initiate Metastatic Outgrowth of Breast Cancer.” Molecular Biology of the Cell 22 (14): 2423–2435. doi:10.1091/mbc.e11-04-0306.
   PubMed Web of Science ®Google Scholar
• Wick, Antje, Annick Desjardins, Cristina Suarez, Peter Forsyth, Ivelina Gueorguieva, Tiana Burkholder, Ann Louise Cleverly, et al. 2020. “Phase 1b/2a Study of Galunisertib, a Small Molecule Inhibitor of Transforming Growth Factor-Beta Receptor I, in Combination with Standard Temozolomide-Based Radiochemotherapy in Patients with Newly Diagnosed Malignant Glioma.” Investigational New Drugs 38 (5): 1570–1579. doi:10.1007/s10637-020-00910-9.
   PubMed Web of Science ®Google Scholar
• Wrana, Jeffrey L., Liliana Attisano, Rotraud Wieser, Francesc Ventura, and Joan Massagué. 1994. “Mechanism of Activation of the TGF-β Receptor.” Nature 370 (6488): 341–347. doi:10.1038/370341a0.
   PubMed Web of Science ®Google Scholar
• Wu, Mary Y., and Caroline S. Hill. 2009. “TGF-β Superfamily Signaling in Embryonic Development and Homeostasis.” Developmental Cell 16 (3): 329–343. doi:10.1016/j.devcel.2009.02.012.
   PubMed Web of Science ®Google Scholar
• Wu, S. P., D. Theodorescu, R. S. Kerbel, J. K. Willson, K. M. Mulder, L. E. Humphrey, and M. G. Brattain. 1992. “TGF-Beta 1 is an Autocrine-Negative Growth Regulator of Human Colon Carcinoma FET Cells in Vivo as Revealed by Transfection of an Antisense Expression Cector.” The Journal of Cell Biology 116 (1): 187–196. doi:10.1083/jcb.116.1.187.
   PubMed Web of Science ®Google Scholar
• XiYang, Yan-Bin, Fang Wang, Bao-Jiang Qian, Ling You, Bing-Tuan Lu, Wei Zhang, Xiong-Zhi Quan, et al. 2013. “Newly Developed TGF-β2 Knockdown Transgenic Mouse Lines Express TGF-β2 Differently and Its Distribution in Multiple Tissues Varies.” BMC Biochemistry 14 (1): 21. doi:10.1186/1471-2091-14-21.
   PubMedGoogle Scholar
• Xu, Jian, Samy Lamouille, and Rik Derynck. 2009. “TGF-β-Induced Epithelial to Mesenchymal Transition.” Cell Research 19 (2): 156–172. doi:10.1038/cr.2009.5.
   PubMed Web of Science ®Google Scholar
• Yan, Xiaohua, Hongwei Liao, Minzhang Cheng, Xiaojing Shi, Xia Lin, Xin-Hua Feng, and Ye-Guang Chen. 2016. “Smad7 Protein Interacts with Receptor-Regulated Smads (R-Smads) to Inhibit Transforming Growth Factor-β (TGF-β)/Smad Signaling.” The Journal of Biological Chemistry 291 (1): 382–392. doi:10.1074/jbc.M115.694281.
   PubMed Web of Science ®Google Scholar
• Yan, Xiaohua, Ziying Liu, and Yeguang Chen. 2009. “Regulation of TGF-β Signaling by Smad7.” Acta Biochimica et Biophysica Sinica 41 (4): 263–272. doi:10.1093/abbs/gmp018.
   PubMed Web of Science ®Google Scholar
• Yan, Xiaohua, Xiangyang Xiong, and Ye-Guang Chen. 2018. “Feedback Regulation of TGF-β Signaling.” Acta Biochimica et Biophysica Sinica 50 (1): 37–50. doi:10.1093/abbs/gmx129.
   PubMed Web of Science ®Google Scholar
• Yang, Haiping, Longqiang Wang, Jun Zhao, Yongbing Chen, Zhe Lei, Xia Liu, Wei Xia, Lingling Guo, and Hong-Tao Zhang. 2015. “TGF-Beta Activated SMAD3/4 Complex Transcriptionally Upregulates N-Cadherin Expression in Non-Small Cell Lung.” Lung Cancer 87 (3): 249–257. doi:10.1016/j.lungcan.2014.12.015.
   PubMed Web of Science ®Google Scholar
• Yang, Xiao, Xinhua Liang, Min Zheng, and Yaling Tang. 2018. “Cellular Phenotype Plasticity in Cancer Dormancy and Metastasis.” Frontiers in Oncology 8: e00505. doi:10.3389/fonc.2018.00505.
   PubMed Web of Science ®Google Scholar
• Yu, Changyun, Yong Liu, Donghai Huang, Yaozhang Dai, Gengming Cai, Jinjie Sun, Ting Xu, Yongquan Tian, and Xin Zhang. 2011. “TGF-β1 Mediates Epithelial to Mesenchymal Transition via the TGF-β/Smad Pathway in Squamous Cell Carcinoma of the Head and Neck.” Oncology Reports 25 (6): 1581–1587. doi:10.3892/or.2011.1251.
   PubMed Web of Science ®Google Scholar
• Zhang, Qing, Xiaonan Hou, Bradley J. Evans, Jamison L. VanBlaricom, Saravut, J., Weroha  , and William A., Cliby. 2018. “LY2157299 Monohydrate, a TGF-βR1 Inhibitor, Suppresses Tumor Growth and Ascites Development in Ovarian Cancer.” Cancers 10 (8): 260. doi:10.3390/cancers10080260.
   PubMed Web of Science ®Google Scholar
• Zhang, Shaqiu, Ni Zeng, Nour Alowayed, Yogesh Singh, Anchun Cheng, Florian Lang, and Madhuri S. Salker. 2017. “Downregulation of Endometrial Mesenchymal Marker SUSD2 Causes Cell Senescence and Cell Death in Endometrial Carcinoma Cells.” PLoS One 12 (8): e0183681. doi:10.1371/journal.pone.0183681.
   PubMed Web of Science ®Google Scholar
• Zhang, Suping, Teng Fei, Lixia Zhang, Ran Zhang, Feng Chen, Yuanheng Ning, Yuna Han, Xin-Hua Feng, Anming Meng, and Ye-Guang Chen. 2007. “Smad7 Antagonizes Transforming Growth Factor β Signaling in the Nucleus by Interfering with Functional Smad-DNA Complex Formation.” Molecular and Cellular Biology 27 (12): 4488–4499. doi:10.1128/MCB.01636-06.
   PubMed Web of Science ®Google Scholar
• Zhang, Ying, Chenbei Chang, Daniel J. Gehling, Ali Hemmati-Brivanlou, and Rik Derynck. 2001. “Regulation of Smad Degradation and Activity by Smurf2, an E3 Ubiquitin Ligase.” Proceedings of the National Academy of Sciences of the United States of America 98 (3): 974–979. doi:10.1073/pnas.98.3.974.
   PubMed Web of Science ®Google Scholar
• Zhang, Ying E. 2009. “Non-Smad Pathways in TGF-β Signaling.” Cell Research 19 (1): 128–139. doi:10.1038/cr.2008.328.
   PubMed Web of Science ®Google Scholar
• Zhu, Hong-Jian, and Antony W. Burgess. 2001. “Regulation of Transforming Growth Factor-β Signaling.” Molecular Cell Biology Research Communications 4 (6): 321–330. doi:10.1006/mcbr.2001.0301.
   PubMedGoogle Scholar
• Zhu, H. J., J. Iaria, and A. M. Sizeland. 1999. “Smad7 Differentially Regulates Transforming Growth Factor β-Mediated Signaling Pathways.” The Journal of Biological Chemistry 274 (45): 32258–32264. doi:10.1074/jbc.274.45.32258.
   PubMed Web of Science ®Google Scholar
• Zhu, Hong-Jian, and Andrew M. Sizeland. 1999a. “Extracellular Domain of the Transforming Growth Factor-β Receptor Negatively Regulates Ligand-Independent Receptor Activation.” The Journal of Biological Chemistry 274 (41): 29220–29227. doi:10.1074/jbc.274.41.29220.
   PubMed Web of Science ®Google Scholar
• Zhu, Hong-Jian, and Andrew M. Sizeland. 1999b. “A Pivotal Role for the Transmembrane Domain in Transforming Growth Factor-β Receptor Activation.” The Journal of Biological Chemistry 274 (17): 11773–11781. doi:10.1074/jbc.274.17.11773.
   PubMed Web of Science ®Google Scholar
• Zi, Zhike, Zipei Feng, Douglas A. Chapnick, Markus Dahl, Difan Deng, Edda Klipp, Aristidis Moustakas, and Xuedong Liu. 2011. “Quantitative Analysis of Transient and Sustained Transforming Growth Factor-β Signaling Dynamics.” Molecular Systems Biology 7 (1): 492. doi:10.1038/msb.2011.22.
   PubMedGoogle Scholar